Related Experiment Video
Updated: Mar 6, 2026

11:15
Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts
Published on: September 1, 2018
8.5K
Advances in Immunotherapy for Glioblastoma Multiforme.
Boyuan Huang1, Hongbo Zhang2, Lijuan Gu3
1Department of Neurosurgery, Beijing Electric Hospital, State Grid, Beijing 100073, China.
Journal of Immunology Research
|March 17, 2017
Summary
Glioblastoma multiforme (GBM) treatment combines surgery, radiation, and chemotherapy, but outcomes remain poor. Emerging immunotherapies, including cancer vaccines and checkpoint inhibitors, show promise for improving glioblastoma survival rates.
Area of Science:
- Neuro-oncology
- Immunotherapy
- Cancer research
Background:
- Glioblastoma multiforme (GBM) is the most aggressive primary brain tumor in adults.
- Current standard treatments (surgery, radiotherapy, temozolomide) offer limited survival benefits.
- Existing therapies highlight the need for novel therapeutic strategies.
Purpose of the Study:
- To explore the potential of immunotherapy for glioblastoma treatment.
- To review advances in cancer vaccines and immune checkpoint blockade for glioma.
- To discuss a future combinatorial and personalized approach for GBM therapy.
Main Methods:
- Review of current literature on glioblastoma treatment.
- Analysis of emerging immunotherapeutic strategies in oncology.
- Synthesis of evidence for combining conventional therapies with immunotherapy.
Main Results:
- Advances in antigen-specific cancer vaccines show promise.
- Immune checkpoint blockade is effective in other advanced tumors.
- Immunotherapy offers a potential new avenue for glioma treatment.
Conclusions:
- Future glioblastoma therapy will likely involve a multimodal approach.
- Combining conventional treatments with immunotherapy is a promising strategy.
- Personalized treatment incorporating immunotherapeutics and checkpoint inhibitors is key.
Related Concept Videos
Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
Cancer Vaccines
1.2K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.2K

